Literature DB >> 20017157

Liver tumor ablation: percutaneous and open approaches.

Srikanth Padma1, John B Martinie, David A Iannitti.   

Abstract

The global incidence of liver cancer is greater than a million cases a year. Surgical resection where applicable is still the standard of care for these patients. Various liver-directed regional therapies have been developed in an effort to treat the vast majority of unresectable liver tumors. This article reviews the principles behind various ablation therapies currently available for malignant liver tumors and their outcomes. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20017157     DOI： 10.1002/jso.21364

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  37 in total

1.  A simple stabilising technique for laparoscopic microwave ablation of liver tumours.

Authors:  A Amer; A Strickland; S White
Journal:  Ann R Coll Surg Engl       Date:  2012-03       Impact factor: 1.891

2.  Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations.

Authors:  Ji-Wei Huang; Roberto Hernandez-Alejandro; Kristopher P Croome; Lu-Nan Yan; Hong Wu; Zhe-Yu Chen; Pankaj Prasoon; Yong Zeng
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

Review 3.  Adopting Gayet's Techniques of Totally Laparoscopic Liver Surgery in the United States.

Authors:  Andrew A Gumbs; Brice Gayet
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

4.  Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging.

Authors:  Fong Ming Hooi; Anna Nagle; Swetha Subramanian; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2015-02       Impact factor: 1.840

Review 5.  Ablation therapy for hepatocellular carcinoma: past, present and future perspectives.

Authors:  David J Niemeyer; Kerri A Simo; David A Iannitti; Iain H McKillop
Journal:  Hepat Oncol       Date:  2013-12-20

6.  Fiber-optic chirped FBG for distributed thermal monitoring of ex-vivo radiofrequency ablation of liver.

Authors:  Daniele Tosi; Edoardo Gino Macchi; Mario Gallati; Giovanni Braschi; Alfredo Cigada; Sandro Rossi; Gabriel Leen; Elfed Lewis
Journal:  Biomed Opt Express       Date:  2014-05-13       Impact factor: 3.732

7.  Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.

Authors:  Jiwei Huang; Roberto Hernandez-Alejandro; Kristopher P Croome; Lvnan Yan; Hong Wu; Zheyu Chen; Pankaj Prasoon; Yong Zeng
Journal:  J Gastrointest Surg       Date:  2010-10-30       Impact factor: 3.452

8.  Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo.

Authors:  Imran A Siddiqui; Eduardo L Latouche; Matthew R DeWitt; Jacob H Swet; Russell C Kirks; Erin H Baker; David A Iannitti; Dionisios Vrochides; Rafael V Davalos; Iain H McKillop
Journal:  HPB (Oxford)       Date:  2016-07-26       Impact factor: 3.647

Review 9.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

10.  Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences?

Authors:  Kerri A Simo; Victor B Tsirline; David Sindram; Matthew T McMillan; Kyle J Thompson; Ryan Z Swan; Iain H McKillop; John B Martinie; David A Iannitti
Journal:  HPB (Oxford)       Date:  2013-03-14       Impact factor: 3.647
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.